This document is the Draft Guideline for Veterinary Good Pharmacovigilance Practices in Egypt (VGVP). It is a comprehensive regulatory framework issued by the Egyptian Drug Authority (EDA), specifically through its Central Administration for Pharmaceutical Care and General Administration for Pharmaceutical Vigilance.
Here is a detailed explanation of the WHO guideline "Recommendations on care for women with diabetes during pregnancy" in English, covering its titles and key details.
Here is a detailed, comprehensive explanation of Root Cause Analysis (RCA), its application in pharmacovigilance, and its critical role in advancing drug safety.
In the high-stakes environment of patient care, we administer powerful medications with the intent to heal, to cure, and to save lives. Yet, for certain critical drugs, this intent rests upon a razor's edge. A single, seemingly minor error—the choice of an incorrect intravenous fluid for reconstitution—can instantly transform a lifesaving therapy into...
Here is a highly detailed, comprehensive explanation of a Risk Management Plan (RMP).
The landscape of healthcare is undergoing a profound shift, moving away from a traditional, paternalistic model towards one that truly prioritizes the patient. At the heart of this transformation lie two interconnected concepts: patient-centered care, a philosophy of collaborative partnership, and the patient experience, the measurable reality of a patient's journey through the healthcare system.
This document, "Guidance on the format of the risk management plan (RMP) in the EU – in integrated format" (EMA/164014/2018 Rev.2.0.1), is an official guideline from the European Medicines Agency (EMA). It provides a standardized template and detailed instructions for pharmaceutical companies (Marketing Authorisation Applicants/Holders) on how to create, structure, and update a Risk...
Advancing Medication Safety Through Knowledge and Vigilance
